Klein Matthew B. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
22
Insider Sells Sum
$3.14M

Insider Activity of Klein Matthew B.

According to the SEC Form 4 filings, Klein Matthew B., being in a position of

  1. director at ClearPoint Neuro, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 16000 shares for $185,440,
    over all time since 2026-05-21, has bought 0 shares, and sold 16000 shares for $185,440.

Biography of Klein Matthew B.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $4,405,32611100

Comparison of Insiders on Amount of Buys and Sells

2026-08-04SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
10,292
0.0122%
$68.57$705,722-4.55%
2026-05-21SaleClearPoint Neuro, Inc.
CLPT
director
16,000
0.0529%
$11.59$185,440+20.38%
2026-05-14SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
12,572
0.0152%
$72.95$917,154-2.83%
2026-04-21SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
2,850
0.0035%
$70.91$202,094-0.13%
2026-03-12SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
2,662
0.0033%
$64.08$170,581+10.62%
2026-02-18SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
7,371
0.0092%
$69.36$511,253+0.54%
2026-01-08SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
2,514
0.0031%
$76.45$192,195-8.31%
2026-01-07SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
3,016
0.0038%
$77.48$233,680-8.73%
2026-01-06SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
5,149
0.0064%
$76.95$396,216-8.07%
2025-12-30SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
8,089
0.0101%
$76.64$619,941-7.34%
2025-12-02SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
3,428
0.0043%
$79.07$271,052-9.66%
2025-08-05SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
10,739
0.0137%
$51.74$555,636+38.25%
2025-04-22SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
2,804
0.004%
$48.74$136,656+36.21%
2025-02-20SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
3,895
0.005%
$50.12$195,233+9.79%
2025-02-19SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
3,897
0.0051%
$50.10$195,224+9.58%
2025-01-08SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
2,402
0.0031%
$44.50$106,889+13.17%
2025-01-07SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
2,142
0.0028%
$45.34$97,118+14.23%
2024-12-31SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
8,279
0.0107%
$45.16$373,880+12.44%
2024-04-19SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
3,361
0.0043%
$24.89$83,669+54.94%
2024-04-17SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
1,307
0.0017%
$25.14$32,851+55.56%
Total: 34
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.